Cytokinetics, Incorporated
CYTKBiotechnology
$63.31+3.31%As of Oct 29vs prior close
- Market cap
- $8.8B
- P/E (TTM)
- –
- From 52W high
- −27.45%
- EPS (LTM)
- -$7.23
- Revenue (LTM)
- $67.7M
- Net margin
- -1321.12%
- Dividend yield
- 0.00%
Nomior Score
35
Steady ProfileSpeculativeBottom 21% of the scored universe
Growth—
Quality21
Value50
Momentum49
Resilience39
Growth
−2.08%revenue a year over 9 fiscal years
FY16 $106.4MLTM $67.7M
Connections
Revenue to profitQ2 FY26
The operating loss was 626% of revenue, wider by 459 pts on a year.
Who owns it
3funds